[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356616-105":59,"doc-detail-356616-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-papillomavirus-based-vs-cytology-for-cervical-cancer-screening-a-systematic-review-with-meta-analysis","Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis","","Objective: evaluate HPV-based testing performance compared with cytology in primary cervical cancer screening. Meta-analysis included randomized trials in women aged 20–69 with at least one year of follow-up, excluding overlapping populations, combined screening approaches, missing outcomes, or protocol-only reports. Searches in CENTRAL, PubMed/MEDLINE, and Embase (April 12, 2025) assessed CIN2+ detection rate. Cochrane and PRISMA methods were used; eight trials included 414,846 patients (per protocol).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-papillomavirus-based-vs-cytology-for-cervical-cancer-screening-a-systematic-review-with-meta-analysis/356616/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-papillomavirus-based-vs-cytology-for-cervical-cancer-screening-a-systematic-review-with-meta-analysis/356616.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of this systematic review and meta-analysis?","Question",{"text":112,"@type":113},"To evaluate the performance of HPV-based testing compared to cytology for primary cervical cancer screening.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies selected for inclusion?",{"text":117,"@type":113},"Randomized trials comparing HPV-based screening with cytology in women aged 20–69 with at least one year of follow-up were included, while studies with overlapping populations, combined screening methods, missing outcomes, or protocol-only reports were excluded.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the main finding regarding CIN2+ detection?",{"text":121,"@type":113},"HPV-based tests showed a 61% higher CIN2+ detection rate than conventional or liquid-based cytology (RR 1.61; 95% CI 1.30–1.98; p \u003C 0.00001), with HPV demonstrating greater sensitivity while raising concerns about possible overdiagnosis and overtreatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356616,1790179657,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review article  \nHuman papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis  \nKellen Crizelda Rocha1  \n [https://orcid.org/0009-0008-0790-7242](https://orcid.org/0009-0008-0790-7242)  \nEverton Bruno Castanha1  \n [https://orcid.org/0000-0003-0989-7849](https://orcid.org/0000-0003-0989-7849)  \nMaria Eduarda Minervino Elias1  \n [https://orcid.org/0009-0005-5368-7533](https://orcid.org/0009-0005-5368-7533)  \nCelene Maria Longoda Silva1  \n [https://orcid.org/0000-0003-3848-0807](https://orcid.org/0000-0003-3848-0807)  \n1Universidade Federal de Pelotas, Pelotas, RS, Brazil.  \nConflicts of interest: none to declare.  \nHow to cite  \nRocha K, Castanha EB, Elias ME, Silva CM. Human papillomavirus-based  \nvs. cytology for cervical cancer screening: a systematic review with meta-analysis. Rev Bras Ginecol Obstet. 2026;48:e-rbgo130.  \nDOI  \n[http://dx.doi.org/10.61622/rbgo/2026rbgo130](http://dx.doi.org/10.61622/rbgo/2026rbgo130)  \nKeywords  \nHuman papillomavirus DNA tests;  \nPapanicolaou test; Uterine cervical dysplasia; Early detection of cancer; Public health  \nSubmitted  \nJune 28, 2025  \nAccepted  \nOctober 22, 2025  \nCorresponding author  \nKellen Crizel da Rocha  \nE-mail: [rch.kellen@gmail.com](rch.kellen@gmail.com)  \nAbstract  \nObjective: To evaluate the performance of HPV-based testing compared to cytology in primary cervical cancer screening.  \nStudy selection: This meta-analysis included randomized trials comparing HPV-based screening with cytology in women aged 20–69 with at least one year of follow-up. Studies with overlapping populations, combining screening methods, lacking outcomes of interest, or study protocols were excluded. CENTRAL, PubMed/MEDLINE, and Embase were searched on April 12, 2025. The main outcome is the detection rate of cervical neoplasia grade 2 or worse (CIN2+) .  \nData collection: Analyses followed Cochrane and PRISMA guidelines.  \nData synthesis: A total of 1,707 articles were identified. After removing duplicate records and excluding studies according to the pre-established criteria, 24 were selected for full-text review. Finally, eight were included in the statistical analysis, totaling 414,846 patients in a per-protocol assessment. The detection rate of CIN2+ by HPV-based tests was 61% higher compared to conventional or liquidbased cytology [RR 1.61; 95% CI 1.30, 1.98; p \u003C 0.00001] . While our findings demonstrate the superior sensitivity of HPV testing, there are concerns about potential overdiagnosis and overtreatment. The absence of defined management protocols for HPV-positive patients contributes to this challenge. Therefore, risk-stratification strategies, such as HPV DNA genotyping, are essential to optimize clinical care and reduce these risks.  \nConclusion: HPV-based screening has a greater capacity to identify cervical neoplasia than cytology.  \nPROSPERO registry: ID CRD420251027259.  \nAssociate Editor  \nJulio Cesar Teixeira  \n([https://orcid.org/0009-0005-3173-4394](https://orcid.org/0009-0005-3173-4394)) Universidade Estadual de Campinas, Campinas, SP, Brasil  \nData availability:  \nThe research data are described in the article  \npresented.  \nRev Bras Ginecol Obstet. 2026;48:e-rbgo130.  1   \nHuman papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis  \nRocha K, Castanha EB, Elias ME, Silva CM  \nIntroduction  \nCervical cancer remains a significant public health concern, particularly in low-and middle-income countries, where access to timely screening and treatment is often limited.(1) Cytology-based screening, widely used globally, has proven effective in reducing mortality and enabling the early detection and treatment of precancerous lesions. However, this strategy has inherent limitations, such as variable sensitivity and reliance on subjective interpretation, which may lead to the underdiagnosis of high-grade squamous intraepithelial lesions (HSIL). The identification of these major cytolo","cbCair4tLlFxP8rc","https://ap.wps.com/l/cbCair4tLlFxP8rc","pdf",618717,"English","# Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What was the objective of this systematic review and meta-analysis?\",\"answer\":\"To evaluate the performance of HPV-based testing compared to cytology for primary cervical cancer screening.\"},{\"question\":\"How were studies selected for inclusion?\",\"answer\":\"Randomized trials comparing HPV-based screening with cytology in women aged 20–69 with at least one year of follow-up were included, while studies with overlapping populations, combined screening methods, missing outcomes, or protocol-only reports were excluded.\"},{\"question\":\"What was the main finding regarding CIN2+ detection?\",\"answer\":\"HPV-based tests showed a 61% higher CIN2+ detection rate than conventional or liquid-based cytology (RR 1.61; 95% CI 1.30–1.98; p \\u003c 0.00001), with HPV demonstrating greater sensitivity while raising concerns about possible overdiagnosis and overtreatment.\"}]","Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis | PDF",1790126317,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70fbe70bd46196dc23f1490f44e38840.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96a176f0d093b4c3fb92a7ed79929c08.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7537ec37652ab05513397adec9f20d47.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a339c44a14860573ec30bf03383448fe.webp",980,1306]